Video Experimental Relacionado
Updated: Sep 9, 2025
07:34
Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
2.7K
Multi-omics descubre programas de transcripción de las células T CD4 + de memoria residentes en el intestino en la
Mitsuru Arase1,2, Mari Murakami1,2, Takako Kihara3
1Department of Microbiology and Immunology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
The Journal of experimental medicine
|September 4, 2025
Resumen
Las células T de memoria residentes en el tejido (TRM) en la enfermedad de Crohn están reguladas por RUNX2 y BHLHE40. Estos factores impulsan las propiedades de las células T específicas de la enfermedad, y su modulación impacta en los fenotipos patógenos, ofreciendo objetivos terapéuticos.
Área de la Ciencia:
- Inmunología
- Biología celular
- Gastroenterología
Sus antecedentes:
- Las células T de memoria residentes en los tejidos (TRM) son cruciales para la memoria inmune en los sitios inflamatorios.
- Un subconjunto único de CD4 + TRM está implicado en la inflamación de la mucosa intestinal de los pacientes con enfermedad de Crohn (EC).
Objetivo del estudio:
- Para caracterizar el subconjunto CD4 + TRM en la mucosa intestinal de la enfermedad de Crohn.
- Identificar los reguladores transcripcionales clave del TRM CD4+ específico de la enfermedad.
Principales métodos:
- Análisis multicapa de una sola célula: cromatina, perfiles genéticos y proteicos.
- Análisis de células T CD4+ derivadas de pacientes y de donantes sanos.
- Evaluación de la función del factor de transcripción (RUNX2, BHLHE40) a través de la desregulación y la sobreexpresión.
Principales resultados:
- Se identificaron RUNX2 y BHLHE40 como reguladores clave del TRM CD4+ patógeno en CD.
- Se ha demostrado que RUNX2/ BHLHE40 induce la citotoxicidad, la actividad del efector T ayudante 1 y la retención de tejidos en CD4+ TRM.
- Se demostró que la regulación a la baja de RUNX2 / BHLHE40 mitiga el fenotipo patógeno de las células T derivadas del paciente.
- Se reveló que la sobreexpresión de RUNX2 / BHLHE40 en células T sanas mejora las vías de IFN-γ y la residencia tisular.
Conclusiones:
- RUNX2 y BHLHE40 orquestan los programas de transcripción que impulsan la formación de células T específicas de la enfermedad de Crohn.
- Dirigirse a RUNX2 y BHLHE40 puede ofrecer una estrategia terapéutica para modular las respuestas de las células T patógenas en CD.
Videos de Conceptos Relacionados
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264
01:30Inflammatory Bowel Disease II: Crohn's Disease
370
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
370
01:23Cells of the Adaptive Immune Response
4.0K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.0K
01:24T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K